coromary artery disease. Atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Iinclusion criteria: Patients referring to the Isfahan Cardiovascular Research center; being pre-hypertensive;stage1 hypertensive ; taking lowering blood pressure drugs; history of myocardial infarction prior 2 months, ten days after coronary angioplasty;3 months after heart bypass surgery Exclusion criteria: Smoking; professional in exercise; participation in an exercise program during the last 3 months; absence for more than three consecutive meetings rehabilitation program; the incidence of acute conditions associated with health; limitations to exercise
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean blood pressure. Timepoint: The bigining and the end of the intervention. Method of measurement: Mmhg- Sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/ dl. Iaboratory measuerments.;Lipid profile. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/ dl. Iaboratory measuerments. | — |
Countries
Iran (Islamic Republic of)
Contacts
Isfahan University of Medical Sciences